TERBINAFINE HYDROCHLORIDE
NDC 68071-2381, Terbinafine Tablets 250 mg, tablet, from NuCare Pharmaceuticals,Inc..
- Product NDC
- 68071-2381
- Status
- Listed
- Labeler
- NuCare Pharmaceuticals,Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA077137
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68071-2381 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TERBINAFINE HYDROCHLORIDE250 mg/1
Pharmacologic classes
Allylamine Antifungal [EPC]; Allylamine [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68071-2381-3 | 68071238103 | 30 TABLET in 1 BOTTLE (68071-2381-3) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/bf020c17-578f-74c4-e053-2995a90a9e7d
Use it
Look up 68071-2381 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68071-2381 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68071-2381. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.